Results 81 to 90 of about 393,600 (259)

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence [version 1; peer review: 2 approved]

Wellcome Open Research, 2019
Carriage of Neisseria meningitidis, the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children.
Holly B. Bratcher, Charlene M. C. Rodrigues, Adam Finn, Mandy Wootton, J. Claire Cameron, Andrew Smith, Paul Heath, Shamez Ladhani, Matthew D. Snape, Andrew J. Pollard, Richard Cunningham, Raymond Borrow, Caroline Trotter, Stephen J. Gray, Martin C. J. Maiden, Jenny M. MacLennan   +15 more
doaj   +1 more source

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia [PDF]

, 1998
A survey for antibodies to a recombinant small viral capsid antigen (sVCA) of human herpesvirus type 8 (HHV‐8) was conducted in Sardinia, one of the world's highest incidence areas for classic Kaposi's sarcoma (KS). Prevalence of antibodies to HHV‐8 sVCA
Angeloni, Antonio, Cerimele, Decio, Cottoni, Francesca Maria Giovanna, Faggioni, Alberto, Heston, Lee, Lin, Su-Fang, Masala, Maria Vittoria, Miller, George, Rigsby, Michael, Sirianni, Maria Caterina, Sun, Ren, Uccini, Stefania   +11 more
core   +1 more source

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

Canada Communicable Disease Report, 2020
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison, Robert Stirling, Oliver Baclic, Wendy Vaudry   +3 more
doaj   +1 more source

A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control

Microorganisms, 2021
Neisseria meningitidis, carried in the human nasopharynx asymptomatically by ~10% of the population, remains a leading cause of meningitis and rapidly fatal sepsis, usually in otherwise healthy individuals.
Yih-Ling Tzeng, David S. Stephens
doaj   +1 more source

Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region

BMC Infectious Diseases, 2021
Invasive meningococcal disease (IMD) represents a global health burden. However, its epidemiology in the Eastern Mediterranean (EM) and North Africa (NA) regions is currently not well understood.
A. Dogu, Anouk M. Oordt-Speets, Femke van Kessel-de Bruijn, M. Ceyhan, A. Amiche   +4 more
semanticscholar   +1 more source

Current safety issues with quadrivalent meningococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj   +1 more source

the course of a invasive meningococcal disease in a patient of military age from specific prophylaxis (clinical case)

Журнал инфектологии, 2020
Meningococcal infection is an acute infectious disease caused by Neisseria meningitidis, characterized by a polymorphism of clinical manifestations from meningococcus carriage to invasive forms.
V. V. Sharabkhanov, K. V. Zhdanov, S. M. Zakharenko, N. I. Lvov, K. V. Kozlov, E. N. Koudelka, Yu. I. Lyashenko, K. S. Ivanov, Yu. I. Bulankov, A. N. Kovalenko, M. V. Yaremenko, V. A. Cheprakova, N. A. Kuvshinova   +12 more
doaj   +1 more source

Self Mutilating Behaviour in Severe Meningococcal Infection; An Interesting Association [PDF]

Journal of Clinical and Diagnostic Research, 2016
Neisseria meningitidis most commonly manifests as asymptomatic colonization in the nasopharynx of healthy adolescents and adults. It may rarely present as invasive disease which may be either bacterial meningitis or meningococcal septicaemia.
Anju Dinkar, Jitendra Singh, Virendra Atam, Krishna Kumar Sahani, Munna Lal Patel   +4 more
doaj   +1 more source

Bacterial outer membrane vesicles and vaccine applications [PDF]

, 2014
Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Acevedo, Reinaldo, Acosta, Armando, Campa, Concepcion, Cardoso, Daniel, Fernandez, Sonsire, Ferro, Valerie, Garcia, Luis, Perez, Jose Luis, Rosenqvist, Einar, Sarmiento, Maria Elena, Zayas, Caridad   +10 more
core   +2 more sources

Invasive Meningococcal Disease and Vaccines

Tuberculin Skin Test in Children, 2013
Meningokok infeksiyonlari butun dunyada onemli saglik sorunlari arasinda yer almaya devam etmektedir. Invaziv Meningokok hastaligi cocukluk caginda % 10 oraninda olumcul olabilmektedir. Vakalarin % 75’inden serogrup A, C, Y ve W135 sorumludur. IMH asilama ile onlenebilir bir hastaliktir.
HANÇERLİ TÖRÜN, Selda, SALMAN, Nuran
openaire   +2 more sources